SCHEDULE: FMR LLC & Abigail Johnson Report 2.1% Stake in Avidity Biosciences
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have filed an amendment to their Schedule 13G, reporting a 2.1% beneficial ownership stake in Avidity Biosciences Inc. as of October 31, 2025.
Summary
- FMR LLC and Abigail P. Johnson jointly filed an Amendment No. 9 to Schedule 13G regarding their beneficial ownership of Avidity Biosciences Inc. common stock.
- As of October 31, 2025, FMR LLC and Abigail P. Johnson beneficially own an aggregate of 2,958,712.25 shares of Avidity Biosciences Inc. common stock.
- This aggregate ownership represents 2.1% of the class of Avidity Biosciences Inc. common stock.
- FMR LLC holds sole voting power over 2,933,428.00 shares and sole dispositive power over 2,958,712.25 shares.
- Abigail P. Johnson holds sole dispositive power over 2,958,712.25 shares.
- Abigail P. Johnson is the Director, Chairman, and Chief Executive Officer of FMR LLC, and through family ownership and a voting agreement, may be deemed part of a controlling group for FMR LLC.
- The filing includes an agreement for joint filing under Rule 13d-1(k)(1).
Sentiment
Score: 6
Explanation: The filing is a routine beneficial ownership disclosure by a major institutional investor, FMR LLC, and its principal, Abigail P. Johnson, maintaining a 2.1% stake in Avidity Biosciences Inc. While not inherently positive or negative, the continued holding by a prominent investor can be seen as a neutral to slightly positive signal of ongoing interest.
Positives
- A significant institutional investor, FMR LLC, and its principal, Abigail P. Johnson, maintain a beneficial ownership stake in Avidity Biosciences Inc., indicating continued interest.
Negatives
- NA
Risks
- NA
Future Outlook
NA
Management Comments
- Stephanie J. Brown, Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries.
- Stephanie J. Brown, Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson.
Industry Context
NA
Stakeholder Impact
- Shareholders: The continued beneficial ownership by a major institutional investor like FMR LLC may be viewed as a sign of confidence in the company's long-term prospects.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC and its subsidiaries. |
| 2023-01-10 | Date of Schedule 13G filing by FMR LLC where Power of Attorney (accession number: -23-000003) was incorporated by reference. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC where Abigail P. Johnson's Power of Attorney (accession number: -23-000038) was incorporated by reference. |
| 2025-10-31 | Date of event which requires filing of this statement (snapshot of beneficial ownership). |
| 2025-11-06 | Date of filing of this Schedule 13G Amendment No. 9. |
Keywords
Avidity Biosciences Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Ownership Disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.